Company Description
Holding company Eurand has pharmaceutical operations in Europe and North America. The company specializes in the development and commercialization...
Key Eurand NV Financials
| Company Type | Public - NASDAQ (GM): EURX Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $123.9 |
| 2006 Employees | 486 |
More Eurand NV Financials (8 pages)
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs....
Read more about Eurand NV's competition across multiple industries
Top Eurand NV Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Eurand NV Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| CEO and Executive Director | Gearóid M. Faherty | Network | E-mail |
| CFO | Mario P. Crovetto | Network | E-mail |
| Chief Commercial Officer | John J. Fraher | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Eurand NV News
- Eurand N.V. (EURX) Corporate Event Announcement Notice [Wall Street Horizon] (18 Jul 2008 21:03:00 EDT)
- Eurand N.V. (EURX) Corporate Event Announcement Notice [Wall Street Horizon] (28 Jun 2008 20:47:00 EDT)
- BioWorld Today June 26, 2008 [BioWorld Today] (26 Jun 2008 00:01:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.